Filing Description Date Filed Sorted Descending Size  
8-K current report Jul 29, 2010 115.3 KB Add to Briefcase
10-Q quarterly report Jul 28, 2010 615.5 KB Add to Briefcase
SC 13G/A amended statement of beneficial ownership Jul 12, 2010 22.1 KB Add to Briefcase
4 vagelos, p roy Jul 9, 2010 20.2 KB Add to Briefcase
4 vagelos, p roy Jun 22, 2010 20.1 KB Add to Briefcase
CT ORDER confidential treatment order Jun 15, 2010 13.3 KB Add to Briefcase
4 ryan, arthur f Jun 15, 2010 18.5 KB Add to Briefcase
8-K current report Jun 14, 2010 16.2 KB Add to Briefcase
4 sing, george l Jun 10, 2010 20.0 KB Add to Briefcase
SC 13G/A amended statement of beneficial ownership Jun 10, 2010 21.5 KB Add to Briefcase
8-K current report Jun 10, 2010 1.6 MB Add to Briefcase
4 kolinski, stuart Jun 7, 2010 21.6 KB Add to Briefcase
4 goldberg, murray a Jun 7, 2010 22.9 KB Add to Briefcase
4 baker, charles a Jun 3, 2010 19.6 KB Add to Briefcase
10-K/A amended annual report Jun 2, 2010 1.1 MB Add to Briefcase
4 gilman, alfred g May 28, 2010 20.5 KB Add to Briefcase
4 brown, michael s May 20, 2010 20.8 KB Add to Briefcase
4 sing, george l May 19, 2010 19.0 KB Add to Briefcase
4 vagelos, p roy May 18, 2010 28.3 KB Add to Briefcase
4 goldstein, joseph l May 17, 2010 20.9 KB Add to Briefcase
Showing 1-20 of 661 Page: 1 2 3 ... 34  Next 20
Add to Briefcase = add filing to Briefcase

The SEC filings provided is for informational purposes only and is not intended for trading purposes. The SEC filings is provided by EDGAR Online, a third party service, and Regeneron Pharmaceuticals, Inc. does not maintain or provide information directly to this service.

Print Print page     Email Email page

Stock Information

NASDAQ:REGN
$23.28   + 0.80
Sep 2, 2010
11:32 AM ET
Quotes delay at least 20min., by eSignal.
Stock price graph
3 Mo.   6 Mo.   1 Yr.

Shareholder Tools

Featured Report